Gpr177 Deficiency Impairs Mammary Development and Prohibits Wnt-Induced Tumorigenesis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Maruyama, Eri Ohfuchi ^a   Yu, H M Ivy ^a   Jiang, Ming ^a   Fu, Jiang ^a   Hsu, Wei ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; ONCOPROTEIN; PROTEIN GPR177; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL DISRUPTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC ANALYSIS; HOMOZYGOSITY; MALIGNANT TRANSFORMATION; MORPHOGENESIS; MOUSE; NONHUMAN; ORGANOGENESIS; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; FEMALE; HYPERPLASIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MORPHOGENESIS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

EID: 84874086149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056644     Document Type: Article

References (54)

1. Lemmon MA, Schlessinger J, (2010) Cell signaling by receptor tyrosine kinases. Cell 141: 1117-1134.
2. Miraoui H, Marie PJ, (2010) Fibroblast growth factor receptor signaling crosstalk in skeletogenesis. Sci Signal 3: re9.
3. McNeill H, Woodgett JR, (2010) When pathways collide: collaboration and connivance among signalling proteins in development. Nat Rev Mol Cell Biol 11: 404-413.
4. Angers S, Moon RT, (2009) Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10: 468-477.
5. Logan CY, Nusse R, (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810.
6. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
7. Visvader JE, (2009) Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 23: 2563-2577.
8. Brennan KR, Brown AM, (2004) Wnt proteins in mammary development and cancer. J Mammary Gland Biol Neoplasia 9: 119-131.
9. Hanahan D, Weinberg RA, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
10. Witsch E, Sela M, Yarden Y, (2010) Roles for growth factors in cancer progression. Physiology (Bethesda) 25: 85-101.
11. Hynes NE, MacDonald G, (2009) ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 21: 177-184.
12. Massague J, (2008) TGFbeta in Cancer. Cell 134: 215-230.
13. Hatsell S, Rowlands T, Hiremath M, Cowin P, (2003) Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8: 145-158.
14. van Amerongen R, Berns A, (2006) Knockout mouse models to study Wnt signal transduction. Trends Genet 22: 678-689.
15. MacDonald BT, Tamai K, He X, (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 17: 9-26.
16. Klaus A, Birchmeier W, (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8: 387-398.
17. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE, (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
18. Coudreuse D, Korswagen HC, (2007) The making of Wnt: new insights into Wnt maturation, sorting and secretion. Development 134: 3-12.
19. Hausmann G, Banziger C, Basler K, (2007) Helping Wingless take flight: how WNT proteins are secreted. Nat Rev Mol Cell Biol 8: 331-336.
20. Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, et al. (2006) Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 11: 791-801.
21. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, et al. (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature.
22. Fu J, Jiang M, Mirando AJ, Yu HM, Hsu W, (2009) Reciprocal regulation of Wnt and Gpr177/mouse Wntless is required for embryonic axis formation. Proc Natl Acad Sci U S A 106: 18598-18603.
23. Fu J, Ivy Yu HM, Maruyama T, Mirando AJ, Hsu W, (2011) Gpr177/mouse Wntless is essential for Wnt-mediated craniofacial and brain development. Dev Dyn 240: 365-371.
24. Yu HM, Jin Y, Fu J, Hsu W, (2010) Expression of Gpr177, a Wnt trafficking regulator, in mouse embryogenesis. Dev Dyn 239: 2102-2109.
25. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, et al. (1997) Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 25: 4323-4330.
26. Hsu W, Mirando AJ, Yu HM, (2010) Manipulating gene activity in Wnt1-expressing precursors of neural epithelial and neural crest cells. Dev Dyn 239: 338-345.
27. Yu HM, Jerchow B, Sheu TJ, Liu B, Costantini F, et al. (2005) The role of Axin2 in calvarial morphogenesis and craniosynostosis. Development 132: 1995-2005.
28. Maruyama T, Mirando AJ, Deng CX, Hsu W, (2010) The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 3: ra40.
29. Maruyama T, Jiang M, Hsu W, (2012) Gpr177, a novel locus for bone-mineral-density and osteoporosis, regulates osteogenesis and chondrogenesis in skeletal development. J Bone Miner Res.
30. Fu J, Hsu W, (2012) Epidermal Wnt Controls Hair Follicle Induction by Orchestrating Dynamic Signaling Crosstalk between the Epidermis and Dermis. J Invest Dermatol.
31. Chiu SY, Asai N, Costantini F, Hsu W, (2008) SUMO-Specific Protease 2 Is Essential for Modulating p53-Mdm2 in Development of Trophoblast Stem Cell Niches and Lineages. PLoS Biol 6: e310.
32. Hsu W, Shakya R, Costantini F, (2001) Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J Cell Biol 155: 1055-1064.
33. Yu HM, Liu B, Costantini F, Hsu W, (2007) Impaired neural development caused by inducible expression of Axin in transgenic mice. Mech Dev 124: 146-156.
34. Yu HM, Liu B, Chiu SY, Costantini F, Hsu W, (2005) Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. Proc Natl Acad Sci U S A 102: 8615-8620.
35. Liu B, Yu HM, Hsu W, (2007) Craniosynostosis caused by Axin2 deficiency is mediated through distinct functions of beta-catenin in proliferation and differentiation. Dev Biol 301: 298-308.
36. Liu B, Yu HM, Huang J, Hsu W, (2008) Co-opted JNK/SAPK signaling in Wnt/beta-catenin-induced tumorigenesis. Neoplasia 10: 1004-1013.
37. Jiang M, Chiu SY, Hsu W, (2010) SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ.
38. Hu Y, Smyth GK, (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. Journal of immunological methods 347: 70-78.
39. Bai L, Rohrschneider LR, (2010) s-SHIP promoter expression marks activated stem cells in developing mouse mammary tissue. Genes Dev 24: 1882-1892.
40. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, et al. (2006) Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
41. Chen B, Dodge ME, Tang W, Lu J, Ma Z, et al. (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5: 100-107.
42. Pastrana E, Silva-Vargas V, Doetsch F, (2011) Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8: 486-498.
43. Hu Y, Smyth GK, (2009) ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 347: 70-78.
44. Cicalese A, Bonizzi G, Pasi CE, Faretta M, Ronzoni S, et al. (2009) The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138: 1083-1095.
45. Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, et al. (2003) Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 100: 15853-15858.
46. Vaillant F, Asselin-Labat ML, Shackleton M, Forrest NC, Lindeman GJ, et al. (2008) The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 68: 7711-7717.
47. Ching W, Nusse R, (2006) A dedicated Wnt secretion factor. Cell 125: 432-433.
48. Port F, Basler K, (2010) Wnt trafficking: new insights into Wnt maturation, secretion and spreading. Traffic 11: 1265-1271.
49. Roarty K, Serra R, (2007) Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 134: 3929-3939.
50. Howe LR, Brown AM, (2004) Wnt signaling and breast cancer. Cancer Biol Ther 3: 36-41.
51. Cho RW, Wang X, Diehn M, Shedden K, Chen GY, et al. (2008) Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors. Stem Cells 26: 364-371.
52. Liu BY, McDermott SP, Khwaja SS, Alexander CM, (2004) The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 101: 4158-4163.
53. Zeng YA, Nusse R, (2010) Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 6: 568-577.
54. Takahashi-Yanaga F, Kahn M, (2010) Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16: 3153-3162.